255 related articles for article (PubMed ID: 24520096)
1. Combined targeting of STAT3/NF-κB/COX-2/EP4 for effective management of pancreatic cancer.
Gong J; Xie J; Bedolla R; Rivas P; Chakravarthy D; Freeman JW; Reddick R; Kopetz S; Peterson A; Wang H; Fischer SM; Kumar AP
Clin Cancer Res; 2014 Mar; 20(5):1259-73. PubMed ID: 24520096
[TBL] [Abstract][Full Text] [Related]
2. Suppression of FAK by nexrutine inhibits gastric cancer progression.
Zhuang K; Guo H; Tang H; Yan Y; Yang Z; Wang Y
Life Sci; 2020 Sep; 257():118100. PubMed ID: 32679149
[TBL] [Abstract][Full Text] [Related]
3. Plumbagin, a plant derived natural agent inhibits the growth of pancreatic cancer cells in in vitro and in vivo via targeting EGFR, Stat3 and NF-κB signaling pathways.
Hafeez BB; Jamal MS; Fischer JW; Mustafa A; Verma AK
Int J Cancer; 2012 Nov; 131(9):2175-86. PubMed ID: 22322442
[TBL] [Abstract][Full Text] [Related]
4. Concurrent inhibition of NF-kappaB, cyclooxygenase-2, and epidermal growth factor receptor leads to greater anti-tumor activity in pancreatic cancer.
Ali S; Banerjee S; Schaffert JM; El-Rayes BF; Philip PA; Sarkar FH
J Cell Biochem; 2010 May; 110(1):171-81. PubMed ID: 20213764
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of STAT3/NF-κB potentiates gemcitabine activity in pancreatic cancer cells.
Gong J; Muñoz AR; Pingali S; Payton-Stewart F; Chan DE; Freeman JW; Ghosh R; Kumar AP
Mol Carcinog; 2017 Feb; 56(2):402-411. PubMed ID: 27208550
[TBL] [Abstract][Full Text] [Related]
6. Direct growth-inhibitory effects of prostaglandin E2 in pancreatic cancer cells in vitro through an EP4/PKA-mediated mechanism.
Schmidt A; Sinnett-Smith J; Young S; Chang HH; Hines OJ; Dawson DW; Rozengurt E; Eibl G
Surgery; 2017 Jun; 161(6):1570-1578. PubMed ID: 28222855
[TBL] [Abstract][Full Text] [Related]
7. Butanol fraction containing berberine or related compound from nexrutine inhibits NFkappaB signaling and induces apoptosis in prostate cancer cells.
Muralimanoharan SB; Kunnumakkara AB; Shylesh B; Kulkarni KH; Haiyan X; Ming H; Aggarwal BB; Rita G; Kumar AP
Prostate; 2009 Apr; 69(5):494-504. PubMed ID: 19107816
[TBL] [Abstract][Full Text] [Related]
8. STAT3 down regulates LC3 to inhibit autophagy and pancreatic cancer cell growth.
Gong J; Muñoz AR; Chan D; Ghosh R; Kumar AP
Oncotarget; 2014 May; 5(9):2529-41. PubMed ID: 24796733
[TBL] [Abstract][Full Text] [Related]
9. Arginine deiminase augments the chemosensitivity of argininosuccinate synthetase-deficient pancreatic cancer cells to gemcitabine via inhibition of NF-κB signaling.
Liu J; Ma J; Wu Z; Li W; Zhang D; Han L; Wang F; Reindl KM; Wu E; Ma Q
BMC Cancer; 2014 Sep; 14():686. PubMed ID: 25240403
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of Pancreatic Cancer In Vitro and In Vivo via Modulation of Nrf2 and NF-κB Signaling Pathways by Natural Compounds.
Cykowiak M; Kleszcz R; Kucińska M; Paluszczak J; Szaefer H; Plewiński A; Piotrowska-Kempisty H; Murias M; Krajka-Kuźniak V
Cells; 2021 Dec; 10(12):. PubMed ID: 34944062
[TBL] [Abstract][Full Text] [Related]
11. Shikonin-mediated PD-L1 degradation suppresses immune evasion in pancreatic cancer by inhibiting NF-κB/STAT3 and NF-κB/CSN5 signaling pathways.
Ruan Z; Liang M; Shang L; Lai M; Deng X; Su X
Pancreatology; 2021 Apr; 21(3):630-641. PubMed ID: 33707115
[TBL] [Abstract][Full Text] [Related]
12. Activation of prostaglandin EP4 receptor attenuates the induction of cyclooxygenase-2 expression by EP2 receptor activation in human amnion fibroblasts: implications for parturition.
Lu JW; Wang WS; Zhou Q; Gan XW; Myatt L; Sun K
FASEB J; 2019 Jul; 33(7):8148-8160. PubMed ID: 30917001
[TBL] [Abstract][Full Text] [Related]
13. JAK2 inhibitor blocks the inflammation and growth of esophageal squamous cell carcinoma in vitro through the JAK/STAT3 pathway.
Fang J; Chu L; Li C; Chen Y; Hu F; Zhang X; Zhao H; Liu Z; Xu Q
Oncol Rep; 2015 Jan; 33(1):494-502. PubMed ID: 25405520
[TBL] [Abstract][Full Text] [Related]
14. Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice.
Shanmugam MK; Rajendran P; Li F; Nema T; Vali S; Abbasi T; Kapoor S; Sharma A; Kumar AP; Ho PC; Hui KM; Sethi G
J Mol Med (Berl); 2011 Jul; 89(7):713-27. PubMed ID: 21465181
[TBL] [Abstract][Full Text] [Related]
15. Ellagic acid and embelin affect key cellular components of pancreatic adenocarcinoma, cancer, and stellate cells.
Edderkaoui M; Lugea A; Hui H; Eibl G; Lu QY; Moro A; Lu X; Li G; Go VL; Pandol SJ
Nutr Cancer; 2013; 65(8):1232-44. PubMed ID: 24127740
[TBL] [Abstract][Full Text] [Related]
16. NF-kappaB/STAT3/PI3K signaling crosstalk in iMyc E mu B lymphoma.
Han SS; Yun H; Son DJ; Tompkins VS; Peng L; Chung ST; Kim JS; Park ES; Janz S
Mol Cancer; 2010 Apr; 9():97. PubMed ID: 20433747
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
18. Calcium-mediated increased expression of fibroblast growth factor-2 acts through NF-κB and PGE2/EP4 receptor signaling pathways in cementoblasts.
Kanaya S; Nemoto E; Sakisaka Y; Shimauchi H
Bone; 2013 Oct; 56(2):398-405. PubMed ID: 23851295
[TBL] [Abstract][Full Text] [Related]
19. Molecular inhibition of prostaglandin E2 with GW627368X: Therapeutic potential and preclinical safety assessment in mouse sarcoma model.
Parida S; Parekh A; Dey G; Ghosh SC; Mandal M
Cancer Biol Ther; 2015; 16(6):922-32. PubMed ID: 25894216
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of gemcitabine can be potentiated in pancreatic cancer through modulation of TLR4/NF-κB signaling by 6-shogaol.
Zhou L; Qi L; Jiang L; Zhou P; Ma J; Xu X; Li P
AAPS J; 2014 Mar; 16(2):246-57. PubMed ID: 24424498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
